News
Commercialization agreement with SHIONOGI for DTx for Insomnia
21/12/27

SUSMED and SHIONOGI have entered into commercialization agreement of DTx for Insomnia.

Previous
Back to list
Next
Latest Article
2025/01/28
ASKA and SUSMED Starts Specified Clinical Trial Using Digital Therapeutics App Designed for Patients with PMS/PMDD
2024/11/07
FISCO Analyst Report
2024/06/05
Presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting about our DTx